Taking Stab at Cancer Genome Sequencing, Illumina and Sanger Institute Analyze Melanoma Genome
September 22, 2009
Taking Stab at Cancer Genome Sequencing, Illumina and Sanger Institute Analyze Melanoma Genome
At the Personal Genomes conference at Cold Spring Harbor Laboratory last week, Illumina chief scientist David Bentley presented results from the company's first cancer genome sequencing project.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Illumina Books Orders for More than 135 MiSeqs, Starts Early-Access Shipments
August 2, 2011 / In Sequence - At AGBT, Sequencing Centers Provide Updates on Capacity, Projects
February 15, 2011 / In Sequence - Stronger-than-Expected Demand for HiSeq Contributes to 50 Percent Boost in Sequencing Sales for Illumina in Q2
August 3, 2010 / In Sequence - Life Tech Sues Illumina over Alleged Infringement of Amplification Patents by Genome Analyzer
September 29, 2009 / In Sequence - The Cost of Sequencing a Human Genome? Answers Differ, Even for the Same Platform
September 15, 2009 / In Sequence